Study guide
10.3 Nutrition Support: Enteral vs. Parenteral
Board Certified Critical Care Pharmacist Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pathophysiology and Recognition of Critical Illness
1.1 Pathophysiology of Shock and Sepsis 1.2 Respiratory Failure and ARDS Pathophysiology 1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome 1.4 Chronic Disease States and Risk Factors for Critical Illness
2 Chapter 2: Medical Devices and Circulatory Support
2.1 Hemodynamic Monitoring and Interpretation 2.2 Mechanical Circulatory Support 2.3 Mechanical Ventilation Modes and Settings 2.4 Continuous Renal Replacement Therapy 2.5 Lines, Tubes, and Drains in Critical Care
3 Chapter 3: Fluid, Electrolyte, and Acid-Base Management
3.1 Resuscitation Fluids: Crystalloids vs. Colloids 3.2 Electrolyte Disorders in the ICU 3.3 Acid-Base Disorders and Interpretation
4 Chapter 4: Vasoactive and Inotropic Therapy in Shock
4.1 Vasopressors in Distributive Shock 4.2 Inotropes and Vasopressors in Cardiogenic and Obstructive Shock
5 Chapter 5: Sedation, Analgesia, and Delirium (PADIS)
5.1 Pain and Analgesia in the ICU 5.2 Sedation Strategies and Medication Selection 5.3 Delirium Assessment, Prevention, and Treatment 5.4 Neuromuscular Blockade in Critical Illness
6 Chapter 6: Cardiovascular Emergencies
6.1 Acute Coronary Syndromes in ICU Patients 6.2 Acute Decompensated Heart Failure 6.3 Hypertensive Emergencies and Arrhythmias
7 Chapter 7: Pulmonary and Infectious Diseases in the ICU
7.1 Severe Sepsis and Septic Shock Antimicrobial Selection 7.2 Pharmacotherapy for Mechanical Ventilation and ARDS 7.3 Severe Infections in the ICU
8 Chapter 8: Neurocritical Care
8.1 Ischemic and Hemorrhagic Stroke Management 8.2 Intracranial Hypertension and Brain Edema 8.3 Status Epilepticus and Sedation in Brain Injury
9 Chapter 9: Toxicology, Endocrine, and Hematologic Emergencies
9.1 Toxicology and Antidote Therapy in the ICU 9.2 Endocrine Emergencies 9.3 Hematologic Emergencies, Anticoagulant Reversal, and Transfusions 9.4 Gastrointestinal and Hepatic Emergencies in the ICU 9.5 Dermatologic and Immunologic Conditions in the ICU 9.6 Trauma, Burns, Supportive Care, and End-of-Life Pharmacotherapy
10 Chapter 10: Special Populations, Pharmacokinetics, and Nutrition
10.1 Altered Pharmacokinetics in Critically Ill Patients 10.2 Therapeutic Drug Monitoring in the ICU 10.3 Nutrition Support: Enteral vs. Parenteral
11 Chapter 11: Quality, Safety, and Clinical Guidelines
11.1 Medication Safety and Error Prevention in the ICU 11.2 Antimicrobial Stewardship and Infection Prevention 11.3 Implementation of Clinical Practice Guidelines 11.4 Healthcare Regulations, Standards, and Drug Interactions
12 Chapter 12: Practice Management, Biostatistics, and Evidence-Based Medicine
12.1 ICU Formulary Management and Cost-Effectiveness 12.2 Biostatistics and Literature Evaluation 12.3 Clinical Trial Interpretation in Critical Care 12.4 Professional Development, Precepting, and ICU Pharmacy Services 12.5 Alternative ICU Delivery Models and Disaster Healthcare Management
13 Chapter 13: Treatment Planning and Care Coordination
13.1 Goals of Care, Perioperative Care, and Transitions of Care 13.2 Medication Delivery Routes and Devices in Critical Illness 13.3 Social Determinants of Health and Patient/Caregiver Education
10.3 Nutrition Support: Enteral vs. Parenteral
Key Takeaways Explain This Topic AI
Enteral nutrition (EN) is preferred over parenteral nutrition (PN) in critically ill patients with a functional gastrointestinal tract due to lower infectious risks and preservation of gut integrity.
Early initiation of EN (within 24-48 hours of ICU admission) is recommended for hemodynamically stable patients.
PN should be reserved for patients who cannot meet nutritional needs enterally, have absolute contraindications to EN (e.g., bowel obstruction, high-output fistula), or are severely malnourished upon admission.
Refeeding syndrome is a potentially fatal complication characterized by severe hypophosphatemia, hypokalemia, and hypomagnesemia upon reintroduction of carbohydrates; risk assessment and cautious feeding are essential.
Indirect calorimetry is the gold standard for determining energy requirements, though predictive equations (e.g., Penn State) are often used when calorimetry is unavailable.
Last updated: July 2026
Nutrition Support: Enteral vs. Parenteral
Quick Answer: The golden rule of ICU nutrition is "If the gut works, use it." Enteral Nutrition (EN) via a feeding tube is the preferred route as it maintains gut mucosal integrity, supports immune function, and has lower infection rates. Parenteral Nutrition (PN) via an IV is reserved for patients who cannot tolerate EN or have a non-functioning GI tract. Early feeding is generally beneficial, but clinicians must carefully monitor for refeeding syndrome.
Critical illness is characterized by a hypermetabolic and catabolic state. Patients rapidly deplete their energy and protein stores, leading to malnutrition, impaired immunity, delayed wound healing, and increased mortality. Providing timely and appropriate nutrition support is a vital component of comprehensive ICU care.
Enteral Nutrition (EN)
Enteral nutrition involves delivering liquid nutrients directly into the gastrointestinal (GI) tract via a feeding tube (e.g., nasogastric, nasojejunal, or percutaneous endoscopic gastrostomy [PEG] tube).
Advantages of EN
EN is the preferred route for nutrition support in patients with a functioning GI tract.
Preservation of Gut Integrity: Feeding the gut maintains the mucosal barrier, preventing the atrophy of intestinal villi and reducing the translocation of gut bacteria into the systemic circulation.
Immune Support: The gut is the largest immune organ in the body. EN stimulates Gut-Associated Lymphoid Tissue (GALT), enhancing overall immune response.
Lower Infection Risk: Compared to Parenteral Nutrition (PN), EN is associated with significantly fewer infectious complications (e.g., central line-associated bloodstream infections).
Cost-Effectiveness: EN is substantially less expensive than PN.
Initiation and Dosing
Early EN: Guidelines recommend initiating EN within 24-48 hours of ICU admission in hemodynamically stable patients.
Hemodynamic Instability: EN should be withheld in patients with severe shock requiring escalating doses of vasopressors, as splanchnic hypoperfusion increases the risk of bowel ischemia. Once resuscitation is complete and vasopressor requirements are stable or weaning, EN can be cautiously started.
Complications of EN
Gastrointestinal Intolerance: High gastric residual volumes, vomiting, diarrhea, and abdominal distension are common. Prokinetic agents (e.g., metoclopramide, erythromycin) may be used to improve gastric emptying.
Aspiration: A significant risk, particularly in patients with altered mental status or delayed gastric emptying. Elevating the head of the bed (30-45 degrees) and using post-pyloric feeding tubes can mitigate this risk.
Parenteral Nutrition (PN)
Parenteral nutrition involves administering a customized admixture of macronutrients (amino acids, dextrose, lipid emulsions) and micronutrients (electrolytes, vitamins, trace elements) intravenously, bypassing the GI tract.
Indications for PN
PN is indicated when the GI tract is non-functional or EN is contraindicated or fails to meet nutritional goals. Absolute contraindications to EN include:
- Intestinal obstruction or severe ileus
- High-output enterocutaneous fistula (where EN cannot bypass the fistula)
- Severe short bowel syndrome
- Intestinal ischemia
- Initiation Timing
Well-Nourished Patients: If EN is not feasible, PN should generally be withheld for the first 7 days of ICU admission to avoid the risks of overfeeding and infectious complications associated with early PN.
Severely Malnourished Patients: In patients with severe baseline malnutrition where EN is contraindicated, PN should be initiated as soon as possible after hemodynamic stability is achieved.
Complications of PN
Infectious Risk: High risk of catheter-related bloodstream infections (CRBSI) due to the need for a central venous catheter and the nutrient-rich PN solution.
Metabolic Derangements: Hyperglycemia (requiring insulin therapy), hypertriglyceridemia, and electrolyte imbalances are frequent.
Hepatobiliary Complications: Long-term PN can lead to hepatic steatosis, cholestasis, and gallbladder sludge.
Refeeding Syndrome
Refeeding syndrome is a potentially fatal metabolic complication that occurs when nutritional support is initiated rapidly in severely malnourished patients.
Pathophysiology
During starvation, the body relies on fat and protein breakdown for energy, and intracellular stores of electrolytes (phosphate, potassium, magnesium) become depleted. When carbohydrates are reintroduced (via EN or PN), insulin secretion spikes. Insulin drives glucose, phosphate, potassium, and magnesium rapidly into the cells, leading to profound serum deficiencies.
Clinical Manifestations
Severe Hypophosphatemia: Can cause respiratory failure (diaphragmatic weakness), heart failure, arrhythmias, and neurological dysfunction.
Hypokalemia and Hypomagnesemia: Contribute to cardiac arrhythmias and neuromuscular weakness.
Prevention and Management
Identify At-Risk Patients: Those with chronic malnutrition, anorexia nervosa, massive weight loss, or chronic alcoholism.
Start Slow: Initiate caloric feeding at a low rate (e.g., 25% of goal) and slowly advance over several days.
Supplement Early: Proactively monitor and aggressively replete potassium, phosphorus, and magnesium before and during the initiation of feeding. Administer thiamine before feeding to prevent Wernicke's encephalopathy.
Assessing Nutritional Needs
Indirect Calorimetry: The "gold standard" for determining resting energy expenditure (REE) by measuring oxygen consumption and carbon dioxide production. It is highly accurate but requires specialized equipment.
Predictive Equations: When indirect calorimetry is unavailable, equations like the Penn State equation (which accounts for minute ventilation and maximum temperature) or simple weight-based formulas (e.g., 25-30 kcal/kg/day) are used to estimate caloric requirements. Protein requirements in the ICU are high, typically ranging from 1.2 to 2.0 g/kg/day.
Clinical Scenario
A 55-year-old male is admitted with severe acute pancreatitis. He is hemodynamically stable but has severe abdominal pain, nausea, and vomiting. An abdominal CT shows significant pancreatic inflammation and a developing ileus.
Nutrition Plan:
Route: Given the severe pancreatitis and ileus, gastric feeding is likely to be poorly tolerated and risks aspiration. However, standard practice emphasizes utilizing the gut. A post-pyloric (jejunal) feeding tube should be placed to bypass the stomach and inflamed pancreas.
Timing: Early EN (within 24-48 hours) via the jejunal tube is initiated, as it is associated with fewer infections and better outcomes compared to delaying feeding or using PN.
PN Consideration: If jejunal feeding fails or the ileus worsens to an obstruction, PN would be considered after 7 days, as he was previously well-nourished.
Monitoring: The team closely monitors for abdominal distension and checks daily electrolyte panels (especially phosphorus, magnesium, and potassium) to watch for refeeding syndrome as the EN rate is advanced.